Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06833 SINCO PHARMA
RT Nominal down0.229 -0.007 (-2.966%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties5,871-1.510%5,9616,1396,3196,499
Property, plant, equip. & others294,600-1.042%297,703279,083258,109207,867
Land & other Lease Assets69,855-5.159%73,65575,12557,73048,394
Intangible Assets116,0646.988%108,48393,64581,5370
Interests in Asso. & JCEs0--0000
Other Non-current Assets5,174113.625%2,4223,4033,2321,029

491,5640.684%488,224457,395406,927263,789
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories274,044-22.221%352,337108,02688,14861,270
Trade Receivables727,07119.535%608,248540,505351,268213,601
Cash & Bank Balances232,625-24.551%308,320437,922329,144326,052
Other Current Assets154,542-36.479%243,294346,830248,846368,054
Assets Held for Sale0--0000

1,388,282-8.194%1,512,1991,433,2831,017,406968,977
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables919,5573.557%887,968866,585407,988422,933
S-T Debt & Leases226,221-34.617%345,996244,690183,804208,704
Other Current Liabilities47,666-51.206%97,688120,762198,79393,999
Liab asso w/ Assets Held for Sale0--0000

1,193,444-10.379%1,331,6521,232,037790,585725,636
Net Current Assets194,8387.915%180,547201,246226,821243,341
Total Assets Less Current Liabilities686,4022.636%668,771658,641633,748507,130
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases1,678-63.048%4,5416,7118,608132,244
Other Non-current Liabilities1,126-16.654%1,35123,87821,3280

2,804-52.410%5,89230,58929,936132,244
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital1640.000%164164164151
  Reserves683,4343.126%662,715627,888603,648374,735
  Others0--0000
Shareholders' Funds683,5983.126%662,879628,052603,812374,886
Non-controlling Interests0--0000
Others0--0000

683,5983.126%662,879628,052603,812374,886
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----98,09918,96145,66085,264
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 11/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 24,389
%Change2.174%
EPS / (LPS)RMB 0.012
NBV Per Share (¥)RMB 0.336
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.